175 related articles for article (PubMed ID: 35878025)
1. Agonist concentration-dependent changes in FPR1 conformation lead to biased signaling for selective activation of phagocyte functions.
Wang J; Ye RD
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2201249119. PubMed ID: 35878025
[TBL] [Abstract][Full Text] [Related]
2. Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2 complex.
Lind S; Dahlgren C; Holmdahl R; Olofsson P; Forsman H
J Leukoc Biol; 2021 Jun; 109(6):1105-1120. PubMed ID: 33040403
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and characterization of fMLF-mimicking AApeptides.
Hu Y; Cheng N; Wu H; Kang S; Ye RD; Cai J
Chembiochem; 2014 Nov; 15(16):2420-6. PubMed ID: 25224835
[TBL] [Abstract][Full Text] [Related]
4. The formyl peptide fMLF primes platelet activation and augments thrombus formation.
Salamah MF; Ravishankar D; Vaiyapuri R; Moraes LA; Patel K; Perretti M; Gibbins JM; Vaiyapuri S
J Thromb Haemost; 2019 Jul; 17(7):1120-1133. PubMed ID: 31033193
[TBL] [Abstract][Full Text] [Related]
5. Identification of formyl peptides from Listeria monocytogenes and Staphylococcus aureus as potent chemoattractants for mouse neutrophils.
Southgate EL; He RL; Gao JL; Murphy PM; Nanamori M; Ye RD
J Immunol; 2008 Jul; 181(2):1429-37. PubMed ID: 18606697
[TBL] [Abstract][Full Text] [Related]
6. Identification of C-terminal phosphorylation sites of N-formyl peptide receptor-1 (FPR1) in human blood neutrophils.
Maaty WS; Lord CI; Gripentrog JM; Riesselman M; Keren-Aviram G; Liu T; Dratz EA; Bothner B; Jesaitis AJ
J Biol Chem; 2013 Sep; 288(38):27042-27058. PubMed ID: 23873933
[TBL] [Abstract][Full Text] [Related]
7. Gliadin Induces Neutrophil Migration via Engagement of the Formyl Peptide Receptor, FPR1.
Lammers KM; Chieppa M; Liu L; Liu S; Omatsu T; Janka-Junttila M; Casolaro V; Reinecker HC; Parent CA; Fasano A
PLoS One; 2015; 10(9):e0138338. PubMed ID: 26378785
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo.
Sogawa Y; Ohyama T; Maeda H; Hirahara K
Immunology; 2011 Mar; 132(3):441-50. PubMed ID: 21039475
[TBL] [Abstract][Full Text] [Related]
9. Propofol inhibits superoxide production, elastase release, and chemotaxis in formyl peptide-activated human neutrophils by blocking formyl peptide receptor 1.
Yang SC; Chung PJ; Ho CM; Kuo CY; Hung MF; Huang YT; Chang WY; Chang YW; Chan KH; Hwang TL
J Immunol; 2013 Jun; 190(12):6511-9. PubMed ID: 23670191
[TBL] [Abstract][Full Text] [Related]
10. A subset of five human mitochondrial formyl peptides mimics bacterial peptides and functionally deactivates human neutrophils.
Kaczmarek E; Hauser CJ; Kwon WY; Riça I; Chen L; Sandler N; Otterbein LE; Campbell Y; Cook CH; Yaffe MB; Marusich MF; Itagaki K
J Trauma Acute Care Surg; 2018 Nov; 85(5):936-943. PubMed ID: 29787548
[TBL] [Abstract][Full Text] [Related]
11. G-protein-coupled formyl peptide receptors play a dual role in neutrophil chemotaxis and bacterial phagocytosis.
Wen X; Xu X; Sun W; Chen K; Pan M; Wang JM; Bolland SM; Jin T
Mol Biol Cell; 2019 Feb; 30(3):346-356. PubMed ID: 30540534
[TBL] [Abstract][Full Text] [Related]
12. Larixol inhibits fMLP-induced superoxide anion production and chemotaxis by targeting the βγ subunit of Gi-protein of fMLP receptor in human neutrophils.
Liao HR; Kao YY; Leu YL; Liu FC; Tseng CP
Biochem Pharmacol; 2022 Jul; 201():115091. PubMed ID: 35569521
[TBL] [Abstract][Full Text] [Related]
13. The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor.
Dahlgren C; Christophe T; Boulay F; Madianos PN; Rabiet MJ; Karlsson A
Blood; 2000 Mar; 95(5):1810-8. PubMed ID: 10688842
[TBL] [Abstract][Full Text] [Related]
14. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
15. The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil chemotaxis by acting as a specific antagonist at the N-formylpeptide receptor subtype FPR.
Liang TS; Gao JL; Fatemi O; Lavigne M; Leto TL; Murphy PM
J Immunol; 2001 Dec; 167(11):6609-14. PubMed ID: 11714831
[TBL] [Abstract][Full Text] [Related]
16. The grape component resveratrol interferes with the function of chemoattractant receptors on phagocytic leukocytes.
Tao HY; Wu CF; Zhou Y; Gong WH; Zhang X; Iribarren P; Zhao YQ; Le YY; Wang JM
Cell Mol Immunol; 2004 Feb; 1(1):50-6. PubMed ID: 16212921
[TBL] [Abstract][Full Text] [Related]
17. The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.
Lavigne MC; Murphy PM; Leto TL; Gao JL
Cell Immunol; 2002; 218(1-2):7-12. PubMed ID: 12470609
[TBL] [Abstract][Full Text] [Related]
18. The role of cytosolic free calcium in the generation of inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate in HL-60 cells. Differential effects of chemotactic peptide receptor stimulation at distinct Ca2+ levels.
Lew PD; Monod A; Krause KH; Waldvogel FA; Biden TJ; Schlegel W
J Biol Chem; 1986 Oct; 261(28):13121-7. PubMed ID: 3489712
[TBL] [Abstract][Full Text] [Related]
19. V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.
Zhou C; Zhou Y; Wang J; Feng Y; Wang H; Xue J; Chen Y; Ye RD; Wang MW
Biochem J; 2013 Apr; 451(2):245-55. PubMed ID: 23373827
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages.
Gemperle C; Schmid M; Herova M; Marti-Jaun J; Wuest SJ; Loretz C; Hersberger M
PLoS One; 2012; 7(11):e50195. PubMed ID: 23185575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
